Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2303]
News [5278]
Articles [130]
Editorials [4]
Conferences [158]
elearning [13]
Addition of thalidomide to myeloma treatment improves response in elderly...
Prof Meral Beksac - Ankara University School of Medicine, Turkey
Addition of thalidomide to myeloma treatment improves response in elderly patients ( Prof Meral Beksac - Ankara University School of Medicine, Turkey )
29 Mar 2011
Role of predictive markers in personalised cancer treatment
Prof Ken O'Byrne - St James's Hospital, Dublin, Ireland
Role of predictive markers in personalised cancer treatment ( Prof Ken O'Byrne - St James's Hospital, Dublin, Ireland )
11 Mar 2011
Targeted maintenance therapies for advanced non-small cell lung cancer
Dr Cesare Gridelli - S.G. Moscati Hospital, Avellino, Italy
Targeted maintenance therapies for advanced non-small cell lung cancer ( Dr Cesare Gridelli - S.G. Moscati Hospital, Avellino, Italy )
10 Mar 2011
Maintenance treatment for advanced non-small cell lung cancer
Prof Filippo de Marinis - Azienda Ospedaliera San Camillo Forlanini, Rome, Italy
Maintenance treatment for advanced non-small cell lung cancer ( Prof Filippo de Marinis - Azienda Ospedaliera San Camillo Forlanini, Rome, Italy )
10 Mar 2011
Key advances in the treatment of lymphoma from ASH 2010
Prof Mathias Rummel, Dr Umberto Vitolo, Prof Johannes Drach, Prof Christian...
Key advances in the treatment of lymphoma from ASH 2010 ( Prof Mathias Rummel, Dr Umberto Vitolo, Prof Johannes Drach, Prof Christian Buske, Prof Owen O'Connor )
28 Feb 2011
Optimal treatment of multiple myeloma
Prof Meletios Dimopoulos, Prof Hermann Einsele, Prof Mario Boccadoro, Dr Maria...
Optimal treatment of multiple myeloma ( Prof Meletios Dimopoulos, Prof Hermann Einsele, Prof Mario Boccadoro, Dr Maria-Victoria Mateos )
28 Feb 2011
Changing the paradigm in frontline CML therapy
Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint...
Changing the paradigm in frontline CML therapy ( Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network )
21 Feb 2011
Administration of bortezomib in multiple myeloma patients
Prof Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France
Administration of bortezomib in multiple myeloma patients ( Prof Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France )
18 Feb 2011
The DASISION chronic myeloid leukaemia trial
Dr Neil Shah - University of California, San Francisco, USA
The DASISION chronic myeloid leukaemia trial ( Dr Neil Shah - University of California, San Francisco, USA )
18 Feb 2011
Key lymphoma research from ASH 2010
Prof Wyndham Wilson - National Cancer Institute, Maryland, USA
Key lymphoma research from ASH 2010 ( Prof Wyndham Wilson - National Cancer Institute, Maryland, USA )
18 Feb 2011
Signalling pathways as a target for cancer therapies
Prof Mariann Bienz - MRC Laboratory of Molecular Biology, Cambridge, UK
Signalling pathways as a target for cancer therapies ( Prof Mariann Bienz - MRC Laboratory of Molecular Biology, Cambridge, UK )
14 Feb 2011
Tumour immunology and combined immunotherapies
Prof Ignacio Melero - University of Navarra, Pamplona, Spain
Tumour immunology and combined immunotherapies ( Prof Ignacio Melero - University of Navarra, Pamplona, Spain )
2 Feb 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation